AI Summary of Peer-Reviewed Research

This page presents an AI-generated summary of a published research paper. The original authors did not write or review this article. [See full disclosure ↓]

Publishing process signals: MODERATE — reflects the venue and review process. — venue and review process.

EV delivery of miR-181a-3p protected degenerating retinal ganglion cells

Biochemistry, Genetics and Molecular Biology research
Photo by Fotorech on Pixabay · Pixabay License
Research area:Biochemistry, Genetics and Molecular BiologyMolecular BiologyNeuroscience and Neural Engineering

What the study found

The study found that extracellular vesicles, which are tiny membrane-bound particles released by cells, could deliver miR-181a-3p to retinal ganglion cells and support their survival and function. Among four candidate microRNAs tested, miR-181a-3p showed the strongest preservation of retinal ganglion cell survival.

Why the authors say this matters

The authors suggest that extracellular vesicles may provide a biocompatible, cell-specific, and functionally effective way to deliver microRNAs to the retina. They conclude that EV-based administration of miR-181a-3p may represent a novel neuroprotective strategy for glaucoma and related optic neuropathies.

What the researchers tested

The researchers screened four candidate microRNAs, selected from prior profiling of injured retinal ganglion cells, in primary rat retinal cultures and human embryonic stem cell-derived retinal ganglion cells. They then loaded miR-181a-3p into extracellular vesicles from R-28 retinal precursor cells using electroporation and assessed particle properties, uptake, distribution, and neuroprotective effects in vitro and in vivo.

What worked and what didn't

miR-181a-3p was the candidate that best preserved retinal ganglion cell survival. EV-mediated delivery of miR-181a-3p improved retinal ganglion cell survival and preserved intracellular calcium dynamics compared with free miRNA or lipofectamine-based transfection, and EV loading improved delivery to the retina in vivo. The EV approach also improved miRNA stability, enabled selective targeting of retinal cell types, and partially modulated the p38/MAPK signalling axis.

What to keep in mind

The abstract does not describe detailed limitations or long-term outcomes. The findings are based on cell culture experiments and in vivo retinal delivery studies, so the summary provided here does not show whether the approach has been tested for clinical use in people.

Key points

  • miR-181a-3p was the strongest of four tested microRNA candidates for preserving retinal ganglion cell survival.
  • Extracellular vesicles from R-28 retinal precursor cells were loaded with miR-181a-3p using electroporation.
  • EV-mediated delivery improved retinal ganglion cell survival and preserved intracellular calcium dynamics better than free miRNA or lipofectamine-based transfection.
  • EV loading improved miRNA stability and retinal delivery in vivo.
  • The authors report partial modulation of the p38/MAPK signalling axis.

Disclosure

Research title:
EV delivery of miR-181a-3p protected degenerating retinal ganglion cells
Authors:
Esmahan Durmaz, Kubra Trabzonlu, Maryam Esmaeili, Hanady Nehme, Lydia Alverez-Erviti, Yasir Ahmed Syed, Aled Clayton, Ben Mead
Institutions:
Alanya University, Cardiff University, Cardiff University, Cardiff University, Cardiff University, Cardiff University, Cardiff University, Center for Biomedical Research of La Rioja
Publication date:
2026-01-21
OpenAlex record:
View
Image credit:
Photo by Fotorech on Pixabay · Pixabay License
AI provenance: This post was generated by gpt-5.4-mini (OpenAI). The original authors did not write or review this post.